Legend Biotech (LEGN) Interest Coverage Ratio Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) Interest Coverage Ratio Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -76.51% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.06% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -303.06% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 75.42% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 67.94% |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -26.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -76.51% |
| Sep 30, 2025 | -39.69% |
| Jun 30, 2025 | -16.56% |
| Mar 31, 2025 | 53.45% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | 136.48% |
| Jun 30, 2024 | -64.06% |
| Mar 31, 2024 | 250.83% |
| Dec 31, 2023 | -60,752,390.97% |
| Sep 30, 2023 | 16.49% |
| Jun 30, 2023 | 22.15% |
| Mar 31, 2023 | 79.16% |
| Dec 31, 2022 | 84.94% |
| Sep 30, 2022 | 89.29% |
| Jun 30, 2022 | 97.65% |
| Mar 31, 2022 | -100.00% |
| Dec 31, 2021 | -777.47% |
| Sep 30, 2021 | 51.14% |
| Jun 30, 2021 | -170.68% |
| Mar 31, 2021 | 2,494,405,465.58% |